269 related articles for article (PubMed ID: 17495946)
1. HSV-1 amplicon-mediated post-transcriptional inhibition of Rad51 sensitizes human glioma cells to ionizing radiation.
Saydam O; Saydam N; Glauser DL; Pruschy M; Dinh-Van V; Hilbe M; Jacobs AH; Ackermann M; Fraefel C
Gene Ther; 2007 Aug; 14(15):1143-51. PubMed ID: 17495946
[TBL] [Abstract][Full Text] [Related]
2. Multitracer positron emission tomographic imaging of exogenous gene expression mediated by a universal herpes simplex virus 1 amplicon vector.
Kummer C; Winkeler A; Dittmar C; Bauer B; Rueger MA; Rueckriem B; Heneka MT; Vollmar S; Wienhard K; Fraefel C; Heiss WD; Jacobs AH
Mol Imaging; 2007; 6(3):181-92. PubMed ID: 17532884
[TBL] [Abstract][Full Text] [Related]
3. Use of herpes simplex virus type 1-based amplicon vector for delivery of small interfering RNA.
Sabbioni S; Callegari E; Manservigi M; Argnani R; Corallini A; Negrini M; Manservigi R
Gene Ther; 2007 Mar; 14(5):459-64. PubMed ID: 17051250
[TBL] [Abstract][Full Text] [Related]
4. Herpes simplex virus 1 amplicon vector-mediated siRNA targeting epidermal growth factor receptor inhibits growth of human glioma cells in vivo.
Saydam O; Glauser DL; Heid I; Turkeri G; Hilbe M; Jacobs AH; Ackermann M; Fraefel C
Mol Ther; 2005 Nov; 12(5):803-12. PubMed ID: 16112910
[TBL] [Abstract][Full Text] [Related]
5. Adenovirus-mediated expression of HSV1-TK or Fas ligand induces cell death in primary human glioma-derived cell cultures that are resistant to the chemotherapeutic agent CCNU.
Maleniak TC; Darling JL; Lowenstein PR; Castro MG
Cancer Gene Ther; 2001 Aug; 8(8):589-98. PubMed ID: 11571537
[TBL] [Abstract][Full Text] [Related]
6. Comparison of herpes simplex virus- and conditionally replicative adenovirus-based vectors for glioblastoma treatment.
Hoffmann D; Wildner O
Cancer Gene Ther; 2007 Jul; 14(7):627-39. PubMed ID: 17479104
[TBL] [Abstract][Full Text] [Related]
7. Gleevec-mediated inhibition of Rad51 expression and enhancement of tumor cell radiosensitivity.
Russell JS; Brady K; Burgan WE; Cerra MA; Oswald KA; Camphausen K; Tofilon PJ
Cancer Res; 2003 Nov; 63(21):7377-83. PubMed ID: 14612536
[TBL] [Abstract][Full Text] [Related]
8. Hypoxia- and radiation-activated Cre/loxP 'molecular switch' vectors for gene therapy of cancer.
Greco O; Joiner MC; Doleh A; Powell AD; Hillman GG; Scott SD
Gene Ther; 2006 Feb; 13(3):206-15. PubMed ID: 16307003
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of homologous recombination by treatment with BVDU (brivudin) or by RAD51 silencing increases chromosomal damage induced by bleomycin in mismatch repair-deficient tumour cells.
Vernole P; Muzi A; Volpi A; Dorio AS; Terrinoni A; Shah GM; Graziani G
Mutat Res; 2009 May; 664(1-2):39-47. PubMed ID: 19428379
[TBL] [Abstract][Full Text] [Related]
10. In vitro and in vivo potentiation of radiosensitivity of malignant gliomas by antisense inhibition of the RAD51 gene.
Ohnishi T; Taki T; Hiraga S; Arita N; Morita T
Biochem Biophys Res Commun; 1998 Apr; 245(2):319-24. PubMed ID: 9571148
[TBL] [Abstract][Full Text] [Related]
11. Neural precursor cells for delivery of replication-conditional HSV-1 vectors to intracerebral gliomas.
Herrlinger U; Woiciechowski C; Sena-Esteves M; Aboody KS; Jacobs AH; Rainov NG; Snyder EY; Breakefield XO
Mol Ther; 2000 Apr; 1(4):347-57. PubMed ID: 10933953
[TBL] [Abstract][Full Text] [Related]
12. Combination of measles virus virotherapy and radiation therapy has synergistic activity in the treatment of glioblastoma multiforme.
Liu C; Sarkaria JN; Petell CA; Paraskevakou G; Zollman PJ; Schroeder M; Carlson B; Decker PA; Wu W; James CD; Russell SJ; Galanis E
Clin Cancer Res; 2007 Dec; 13(23):7155-65. PubMed ID: 18056196
[TBL] [Abstract][Full Text] [Related]
13. Rad51 siRNA delivered by HVJ envelope vector enhances the anti-cancer effect of cisplatin.
Ito M; Yamamoto S; Nimura K; Hiraoka K; Tamai K; Kaneda Y
J Gene Med; 2005 Aug; 7(8):1044-52. PubMed ID: 15756713
[TBL] [Abstract][Full Text] [Related]
14. Combination of pGL1-TNF-alpha gene and radiation (proton and gamma-ray) therapy against brain tumor.
Gridley DS; Li J; Kajioka EH; Andres ML; Moyers MF; Slater JM
Anticancer Res; 2000; 20(6B):4195-203. PubMed ID: 11205248
[TBL] [Abstract][Full Text] [Related]
15. Quantitation of HSV mass distribution in a rodent brain tumor model.
Schellingerhout D; Rainov NG; Breakefield XO; Weissleder R
Gene Ther; 2000 Oct; 7(19):1648-55. PubMed ID: 11083473
[TBL] [Abstract][Full Text] [Related]
16. Herpes simplex virus delivery to orthotopic rectal carcinoma results in an efficient and selective antitumor effect.
Kolodkin-Gal D; Edden Y; Hartshtark Z; Ilan L; Khalaileh A; Pikarsky AJ; Pikarsky E; Rabkin SD; Panet A; Zamir G
Gene Ther; 2009 Jul; 16(7):905-15. PubMed ID: 19440231
[TBL] [Abstract][Full Text] [Related]
17. Enhanced antiglioma activity of chimeric HCMV/HSV-1 oncolytic viruses.
Shah AC; Parker JN; Gillespie GY; Lakeman FD; Meleth S; Markert JM; Cassady KA
Gene Ther; 2007 Jul; 14(13):1045-54. PubMed ID: 17429445
[TBL] [Abstract][Full Text] [Related]
18. Antitumoral effects of defective herpes simplex virus-mediated transfer of tissue inhibitor of metalloproteinases-2 gene in malignant glioma U87 in vitro: consequences for anti-cancer gene therapy.
Hoshi M; Harada A; Kawase T; Uyemura K; Yazaki T
Cancer Gene Ther; 2000 May; 7(5):799-805. PubMed ID: 10830727
[TBL] [Abstract][Full Text] [Related]
19. Normal brain cells contribute to the bystander effect in suicide gene therapy of malignant glioma.
Miletic H; Fischer YH; Giroglou T; Rueger MA; Winkeler A; Li H; Himmelreich U; Stenzel W; Jacobs AH; von Laer D
Clin Cancer Res; 2007 Nov; 13(22 Pt 1):6761-8. PubMed ID: 18006778
[TBL] [Abstract][Full Text] [Related]
20. Radiation-inducible caspase-8 gene therapy for malignant brain tumors.
Tsurushima H; Yuan X; Dillehay LE; Leong KW
Int J Radiat Oncol Biol Phys; 2008 Jun; 71(2):517-25. PubMed ID: 18407431
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
